Clinical Trials Browser

INDUSTRY × Mouth Diseases × Clear all

Disease, Erythroplasia, Hyperplasia, Leukoplakia, Mouth Diseases, Keratoderma, Palmoplantar, Epidermolytic

NCT00323518 2016-04-13

A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis

Phase 2 Completed

390 enrolled

Mouth Diseases, Stomatitis

NCT00104065 2016-03-15

Safety and Efficacy of CG53135-05 in the Prevention of Oral Mucositis in Patients Receiving Bone Marrow Transplant

Phase 2 Completed

Mouth Diseases, Stomatitis

NCT01247246 2014-05-26

Study to Evaluate the Efficacy and Safety of Three Different Doses of SCV 07 in Attenuating Oral Mucositis in Subjects With Head and Neck Cancer

Phase 2 Unknown

160 enrolled

GastrointestinalHead & NeckOther

Digestive System Diseases, Gastroenteritis, Gastrointestinal Diseases, Head and Neck Neoplasms, Stomatognathic Diseases, Mouth Diseases, Neoplasms, Neoplasms by Site, Stomatitis, Mucositis

NCT00230191 2007-01-15

Safety and Efficacy of RK0202 in Oral Mucositis

Phase 2 Completed

110 enrolled

Head & NeckOther

Head and Neck Neoplasms, Mouth Diseases, Stomatitis, Oral Ulcer, Mucositis

Clinical Trials

Evaluation of Oral Potentially Malignant Disorders (OPMDs) with STRATICYTE™

A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis

Safety and Efficacy of CG53135-05 in the Prevention of Oral Mucositis in Patients Receiving Bone Marrow Transplant

Study to Evaluate the Efficacy and Safety of Three Different Doses of SCV 07 in Attenuating Oral Mucositis in Subjects With Head and Neck Cancer

Safety and Efficacy of RK0202 in Oral Mucositis